What's Happening?
Plantimex Distributors has initiated a recall of approximately 50,000 containers of Mamisan Pain Relieving Topical Ointment. The recall is due to the product's packaging failing to meet child-resistant safety standards, as required by the U.S. Consumer
Product Safety Commission (CPSC). The ointment, which contains the numbing agent lidocaine, poses a potential poisoning risk if ingested by children. The product was sold in bright orange jars with twist-off lids at major retailers such as Walmart and Target, as well as online at Target.com, from April 2024 to October 2025. The recall specifically targets jars with the UPC code 860006498115. Consumers are advised to keep the ointment out of children's reach and contact Plantimex for a free replacement lid.
Why It's Important?
This recall highlights significant safety concerns regarding consumer products, particularly those that may be accessible to children. The failure to meet child-resistant packaging standards poses a serious risk of accidental poisoning, which can have severe health implications. The recall underscores the importance of regulatory compliance in product packaging to prevent potential hazards. For retailers like Walmart and Target, this incident may prompt a review of their product safety protocols to ensure compliance with safety standards. For consumers, it serves as a reminder to be vigilant about product safety, especially for items that could be harmful if ingested by children.
What's Next?
Consumers who have purchased the affected ointment are encouraged to contact Plantimex for a replacement lid to ensure the product is safe for use. The company has provided contact information for consumers to request the replacement. Retailers may also take steps to remove the affected products from their shelves and online platforms to prevent further sales. The CPSC may continue to monitor the situation to ensure compliance and prevent similar issues in the future. This recall may lead to increased scrutiny of other products with similar packaging concerns.
